BNTX - FDA recommends KP.2 strain be used in updated COVID-19 shots
2024-06-13 18:34:04 ET
More on BioNTech, Moderna, etc.
- BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical
- Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon
- Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Moderna reaffirms Phase 3 win for next-gen COVID shot
- Sarepta gains after Pfizer’s late-stage setback for Duchenne therapy